Latest Insider Transactions at Medifast Inc (MED)
This section provides a real-time view of insider transactions for Medifast Inc (MED). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MEDIFAST INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MEDIFAST INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2023
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
57
-8.81%
|
$5,928
$104.46 P/Share
|
|
Mar 16
2023
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
123
-4.18%
|
$12,792
$104.46 P/Share
|
|
Mar 16
2023
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,358
-4.17%
|
$141,232
$104.46 P/Share
|
|
Mar 10
2023
|
Scott Schlackman Director |
SELL
Open market or private sale
|
Direct |
2,200
-23.21%
|
$237,600
$108.68 P/Share
|
|
Mar 10
2023
|
Scott Schlackman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+18.84%
|
$59,400
$27.68 P/Share
|
|
Feb 24
2023
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,643
-32.46%
|
$1,705,087
$109.99 P/Share
|
|
Feb 24
2023
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
34,076
+41.42%
|
-
|
|
Feb 21
2023
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,815
-11.39%
|
$208,725
$115.31 P/Share
|
|
Feb 07
2023
|
Michael A. Hoer Director |
BUY
Open market or private purchase
|
Direct |
9
+0.17%
|
$1,026
$114.97 P/Share
|
|
Feb 07
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Direct |
11
+0.46%
|
$1,254
$114.97 P/Share
|
|
Feb 07
2023
|
Constance J. Hallquist |
BUY
Open market or private purchase
|
Direct |
9
+0.12%
|
$1,026
$114.97 P/Share
|
|
Feb 07
2023
|
Scott Schlackman Director |
BUY
Open market or private purchase
|
Direct |
9
+0.12%
|
$1,026
$114.97 P/Share
|
|
Feb 07
2023
|
Andrea B Thomas Director |
BUY
Open market or private purchase
|
Direct |
9
+0.3%
|
$1,026
$114.97 P/Share
|
|
Feb 03
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
570
+1.37%
|
$66,120
$116.11 P/Share
|
|
Nov 08
2022
|
Constance J. Hallquist |
BUY
Open market or private purchase
|
Direct |
10
+0.13%
|
$1,060
$106.93 P/Share
|
|
Nov 08
2022
|
Michael A. Hoer Director |
BUY
Open market or private purchase
|
Direct |
10
+0.19%
|
$1,060
$106.93 P/Share
|
|
Nov 08
2022
|
Scott Schlackman Director |
BUY
Open market or private purchase
|
Direct |
10
+0.14%
|
$1,060
$106.93 P/Share
|
|
Nov 08
2022
|
Andrea B Thomas Director |
BUY
Open market or private purchase
|
Direct |
10
+0.33%
|
$1,060
$106.93 P/Share
|
|
Nov 08
2022
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Direct |
11
+0.46%
|
$1,166
$106.93 P/Share
|
|
Nov 04
2022
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
560
+1.51%
|
$58,800
$105.06 P/Share
|
|
Sep 13
2022
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-1.52%
|
$1,240
$124.56 P/Share
|
|
Aug 09
2022
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
3,940
+48.63%
|
$496,440
$126.17 P/Share
|
|
Aug 08
2022
|
Scott Schlackman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.1%
|
$966
$138.78 P/Share
|
|
Aug 08
2022
|
Andrea B Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.23%
|
$966
$138.78 P/Share
|
|
Aug 08
2022
|
Michael A. Hoer Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.14%
|
$966
$138.78 P/Share
|
|
Aug 08
2022
|
Constance J. Hallquist |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.1%
|
$1,104
$138.78 P/Share
|
|
Aug 08
2022
|
Jeffrey J Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.38%
|
$1,242
$138.78 P/Share
|
|
Aug 04
2022
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
399
+1.1%
|
$58,254
$146.01 P/Share
|
|
Jul 20
2022
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-3.76%
|
$20,010
$174.44 P/Share
|
|
Jun 16
2022
|
Andrea B Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,366
+31.24%
|
-
|
|
Jun 16
2022
|
Constance J. Hallquist |
BUY
Grant, award, or other acquisition
|
Direct |
1,432
+15.39%
|
-
|
|
Jun 16
2022
|
Jeffrey J Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,580
+40.25%
|
-
|
|
Jun 16
2022
|
Michael A. Hoer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,350
+20.83%
|
-
|
|
Jun 16
2022
|
Scott Schlackman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,448
+16.64%
|
-
|
|
May 05
2022
|
Daniel R Chard Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
431
+0.4%
|
$78,873
$183.25 P/Share
|
|
May 05
2022
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
315
+0.88%
|
$57,645
$183.25 P/Share
|
|
Mar 21
2022
|
Daniel R Chard Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
953
+0.87%
|
-
|
|
Mar 21
2022
|
Daniel R Chard Chairman & CEO |
SELL
Bona fide gift
|
Direct |
953
-5.64%
|
-
|
|
Mar 17
2022
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
878
-4.15%
|
$158,040
$180.52 P/Share
|
|
Mar 17
2022
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
75
-2.39%
|
$13,500
$180.52 P/Share
|
|
Mar 16
2022
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,509
+28.7%
|
-
|
|
Mar 16
2022
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
548
+45.48%
|
-
|
|
Mar 16
2022
|
James P. Maloney Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,281
+29.01%
|
-
|
|
Mar 10
2022
|
Andrea B Thomas Director |
SELL
Open market or private sale
|
Direct |
1,150
-41.22%
|
$200,100
$174.31 P/Share
|
|
Feb 23
2022
|
Daniel R Chard Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
3,375
+3.05%
|
-
|
|
Feb 23
2022
|
Daniel R Chard Chairman & CEO |
SELL
Bona fide gift
|
Direct |
3,375
-16.66%
|
-
|
|
Feb 22
2022
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,086
-10.35%
|
$546,222
$177.06 P/Share
|
|
Feb 04
2022
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
266
+0.75%
|
$49,476
$186.4 P/Share
|
|
Feb 04
2022
|
Daniel R Chard Chairman & CEO |
BUY
Open market or private purchase
|
Indirect |
690
+0.66%
|
$128,340
$186.4 P/Share
|
|
Jan 03
2022
|
Daniel R Chard Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
12,539
+10.84%
|
-
|